Lung Cancer

Surgical Treatment of Spinal Cord Compression Caused by Metastatic Small Cell Lung Cancer: Ten Years of Experience in a Single Center

Publish Date July 10, 2020

[Cancer Management and Research] A retrospective review of 30 patients who underwent resection of spinal tumor caused by metastatic SCLC demonstrated that surgery was critical to improving patients QOL and performance status.

Racial Disparities Seen in PET/CT Imaging for Lung Cancer

Publish Date June 26, 2020

Black, Hispanic patients less likely to receive recommended imaging at time of diagnosis of NSCLC.

FDA Approves Keytruda for Tumor Mutational Burden-High Cancer

By

Brian Park, PharmD

Publish Date June 22, 2020

The accelerated approval was based on data from a prospectively-planned retrospective analysis of 10 cohorts of patients with various previously treated unresectable or metastatic solid tumors with TMB-H who were enrolled in the open-label phase 2 KEYNOTE-158 trial.

COVID-19 Death Rate High for Patients With Thoracic Cancer

Publish Date June 18, 2020

Of those eligible for intensive care unit admission, only 10 percent admitted to ICU.

Zepzelca Approved for Metastatic Small Cell Lung Cancer

By

Diana Ernst, RPh

Publish Date June 17, 2020

The FDA has approved Zepzelca™ (lurbinectedin; Jazz Pharmaceuticals) for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)

Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)